A Clinical Review on HMG-CoA Reductase Inhibitors (Statins)-induced Hyperglycemia and New-onset Diabetes Mellitus (NODM)
{{output}}
Introduction: Due to their potent lipid-lowering capabilities, 3-hydroxy-3- methylglutyryl-coenzyme A (HMG-CoA) reductase inhibitors, commonly referred to as statins, are widely utilized for the primary and secondary prevention o... ...
